Olodaterol

🧮 Dose calculator

Chronic obstructive pulmonary disease (COPD) · Regimen source: FDA Striverdi Respimat · 2

• • Not more than 2 inhalations every 24 h. Not indicated for asthma. FDA Striverdi Respimat · 2FDA Striverdi Respimat · 4

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Striverdi Respimat · 8.1

  “Risk Summary There are no adequate and well-controlled clinical studies with STRIVERDI RESPIMAT in pregnant women to inform of drug-associated risk of adverse pregnancy-related outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Striverdi Respimat · 8.2

  “Risk Summary There are no available data on the presence of olodaterol in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Striverdi Respimat · 8.4

  “The safety and effectiveness of STRIVERDI RESPIMAT in the pediatric population have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Striverdi Respimat · 8.5

  “No overall differences in effectiveness were observed, and in the 1-year pooled data, the adverse drug reaction profiles were similar in the older population compared to the patient population overall.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.